Calidi Biotherapeutics board member Dr. Heehyoung Lee resigns effective immediately

Calidi Biotherapeutics, Inc.

Dr. Heehyoung Lee resigned from the Board and all committees on October 10, 2023.
Resignation is for personal reasons, not due to any disagreement with management or the Board.
No replacement director has been announced as of the filing date.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Dr. Heehyoung Lee

Director

CLDI · Calidi Biotherapeutics, Inc.

Effective: 2023-10-10
Filed: October 16, 2023, 7:59 PM ET

On October 10, 2023, the Company announced the resignation of Dr. Heehyoung Lee, including all her positions on the committees of the Board, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Dr. Heehyoung Lee resigned as Director at Calidi Biotherapeutics, Inc..

Action: resigned
Role: Director

Exact text from the filing

On October 10, 2023, the Company announced the resignation of Dr. Heehyoung Lee, including all her positions on the committees of the Board, effective immediately.

View on SEC.gov

Calidi Biotherapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-037376

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.